{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:59:39Z","timestamp":1788929979201,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":102,"publisher":"Springer US","isbn-type":[{"value":"9781071607701","type":"print"},{"value":"9781071607718","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0771-8_1","type":"book-chapter","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T07:02:49Z","timestamp":1598857369000},"page":"3-19","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Invention and Early History of Gapmers"],"prefix":"10.1007","author":[{"given":"Kenji Rowel Q.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1534\/genetics.111.136911","volume":"190","author":"G Prelich","year":"2012","unstructured":"Prelich G (2012) Gene overexpression: uses, mechanisms, and interpretation. Genetics 190:841\u2013854. https:\/\/doi.org\/10.1534\/genetics.111.136911","journal-title":"Genetics"},{"key":"1_CR2","doi-asserted-by":"publisher","unstructured":"Bolognesi B, Lehner B (2018) Protein overexpression: reaching the limit. Elife. https:\/\/doi.org\/10.7554\/eLife.39804","DOI":"10.7554\/eLife.39804"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrd3050","volume":"9","author":"A Aguzzi","year":"2010","unstructured":"Aguzzi A, O\u2019Connor T (2010) Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 9:237\u2013248. https:\/\/doi.org\/10.1038\/nrd3050","journal-title":"Nat Rev Drug Discov"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1042\/EBC20170053","volume":"62","author":"M Jackson","year":"2018","unstructured":"Jackson M, Marks L, May GHW, Wilson JB (2018) The genetic basis of disease. Essays Biochem 62:643\u2013723. https:\/\/doi.org\/10.1042\/EBC20170053","journal-title":"Essays Biochem"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11910-016-0667-0","volume":"16","author":"LH Wang","year":"2016","unstructured":"Wang LH, Tawil R (2016) Facioscapulohumeral dystrophy. Curr Neurol Neurosci Rep 16:66. https:\/\/doi.org\/10.1007\/s11910-016-0667-0","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.chembiol.2011.12.008","volume":"19","author":"JC Burnett","year":"2012","unstructured":"Burnett JC, Rossi JJ (2012) RNA-based therapeutics: current Progress and future prospects. Chem Biol 19:60\u201371. https:\/\/doi.org\/10.1016\/j.chembiol.2011.12.008","journal-title":"Chem Biol"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1073\/pnas.75.1.285","volume":"75","author":"ML Stephenson","year":"1978","unstructured":"Stephenson ML, Zamecnik PC (1978) Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc Natl Acad Sci U S A 75:285\u2013288. https:\/\/doi.org\/10.1073\/pnas.75.1.285","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1073\/pnas.75.1.280","volume":"75","author":"PC Zamecnik","year":"1978","unstructured":"Zamecnik PC, Stephenson ML (1978) Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A 75:280\u2013284. https:\/\/doi.org\/10.1073\/pnas.75.1.280","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","volume":"50","author":"CF Bennett","year":"2010","unstructured":"Bennett CF, Swayze EE (2010) RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu Rev Pharmacol Toxicol 50:259\u2013293. https:\/\/doi.org\/10.1146\/annurev.pharmtox.010909.105654","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-8651-4_1","volume-title":"Exon Skipp. Incl. Ther. Methods Protoc","author":"KRQ Lim","year":"2018","unstructured":"Lim KRQ, Yokota T (2018) Invention and early history of exon skipping and splice modulation. In: Yokota T, Maruyama R (eds) Exon Skipp. Incl. Ther. Methods Protoc. Springer, New York, pp 3\u201330"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s40265-013-0042-2","volume":"73","author":"P Hair","year":"2013","unstructured":"Hair P, Cameron F, McKeage K (2013) Mipomersen sodium: first global approval. Drugs 73:487\u2013493. https:\/\/doi.org\/10.1007\/s40265-013-0042-2","journal-title":"Drugs"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s40265-018-0968-5","volume":"78","author":"SJ Keam","year":"2018","unstructured":"Keam SJ (2018) Inotersen: first global approval. Drugs 78:1371\u20131376. https:\/\/doi.org\/10.1007\/s40265-018-0968-5","journal-title":"Drugs"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","volume":"46","author":"X Shen","year":"2018","unstructured":"Shen X, Corey DR (2018) Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs. Nucleic Acids Res 46:1584\u20131600. https:\/\/doi.org\/10.1093\/nar\/gkx1239","journal-title":"Nucleic Acids Res"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/j.1742-4658.2009.06908.x","volume":"276","author":"SM Cerritelli","year":"2009","unstructured":"Cerritelli SM, Crouch RJ (2009) Ribonuclease H: the enzymes in eukaryotes. FEBS J 276:1494\u20131505. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.06908.x","journal-title":"FEBS J"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3389\/fmicb.2017.01745","volume":"8","author":"K Moelling","year":"2017","unstructured":"Moelling K, Broecker F, Russo G, Sunagawa S (2017) RNase H as gene modifier, driver of evolution and antiviral defense. Front Microbiol 8:1745. https:\/\/doi.org\/10.3389\/fmicb.2017.01745","journal-title":"Front Microbiol"},{"issue":"3","key":"1_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/bfgp\/ely024","volume":"18","author":"K Kojima","year":"2018","unstructured":"Kojima K, Baba M, Tsukiashi M et al (2018) RNA\/DNA structures recognized by RNase H2. Brief Funct Genomics 18(3):169\u2013173. https:\/\/doi.org\/10.1093\/bfgp\/ely024","journal-title":"Brief Funct Genomics"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1126\/science.166.3903.393","volume":"166","author":"H Stein","year":"1969","unstructured":"Stein H, Hausen P (1969) Enzyme from calf thymus degrading the RNA moiety of DNA-RNA hybrids: effect on DNA-dependent RNA polymerase. Science 166:393\u2013395","journal-title":"Science"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1432-1033.1975.tb03985.x","volume":"52","author":"W Busen","year":"1975","unstructured":"Busen W, Hausen P (1975) Distinct Ribonuclease H activities in calf thymus. Eur J Biochem 52:179\u2013190. https:\/\/doi.org\/10.1111\/j.1432-1033.1975.tb03985.x","journal-title":"Eur J Biochem"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1097-2765(03)00088-1","volume":"11","author":"SM Cerritelli","year":"2003","unstructured":"Cerritelli SM, Frolova EG, Feng C et al (2003) Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice. Mol Cell 11:807\u2013815","journal-title":"Mol Cell"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1084\/jem.20120876","volume":"209","author":"B Hiller","year":"2012","unstructured":"Hiller B, Achleitner M, Glage S et al (2012) Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J Exp Med 209:1419\u20131426. https:\/\/doi.org\/10.1084\/jem.20120876","journal-title":"J Exp Med"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.autrev.2012.08.012","volume":"12","author":"E Fazzi","year":"2013","unstructured":"Fazzi E, Cattalini M, Orcesi S et al (2013) Aicardi\u2013Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? Autoimmun Rev 12:506\u2013509. https:\/\/doi.org\/10.1016\/j.autrev.2012.08.012","journal-title":"Autoimmun Rev"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"12872","DOI":"10.1073\/pnas.95.22.12872","volume":"95","author":"P Frank","year":"1998","unstructured":"Frank P, Braunshofer-Reiter C, Wintersberger U et al (1998) Cloning of the cDNA encoding the large subunit of human RNase HI, a homologue of the prokaryotic RNase HII. Proc Natl Acad Sci 95:12872\u201312877. https:\/\/doi.org\/10.1073\/pnas.95.22.12872","journal-title":"Proc Natl Acad Sci"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0300-9084(93)90033-O","volume":"75","author":"PS Eder","year":"1993","unstructured":"Eder PS, Walder RY, Walder JA (1993) Substrate specificity of human RNase H1 and its role in excision repair of ribose residues misincorporated in DNA. Biochimie 75:123\u2013126","journal-title":"Biochimie"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"10530","DOI":"10.1074\/jbc.M110.177394","volume":"286","author":"MAM Reijns","year":"2011","unstructured":"Reijns MAM, Bubeck D, Gibson LCD et al (2011) The structure of the human RNase H2 complex defines key interaction interfaces relevant to enzyme function and human disease. J Biol Chem 286:10530\u201310539. https:\/\/doi.org\/10.1074\/jbc.M110.177394","journal-title":"J Biol Chem"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0165-022X(01)00149-X","volume":"48","author":"E Zamaratski","year":"2001","unstructured":"Zamaratski E, Pradeepkumar PI, Chattopadhyaya J (2001) A critical survey of the structure-function of the antisense oligo\/RNA heteroduplex as substrate for RNase H. J Biochem Biophys Methods 48:189\u2013208","journal-title":"J Biochem Biophys Methods"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0167-4781(99)00152-9","volume":"1489","author":"P Herdewijn","year":"1999","unstructured":"Herdewijn P (1999) Conformationally restricted carbohydrate-modified nucleic acids and antisense technology. Biochim Biophys Acta 1489:167\u2013179","journal-title":"Biochim Biophys Acta"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1073\/pnas.74.10.4370","volume":"74","author":"BM Paterson","year":"1977","unstructured":"Paterson BM, Roberts BE, Kuff EL (1977) Structural gene identification and mapping by DNA-mRNA hybrid-arrested cell-free translation. Proc Natl Acad Sci U S A 74:4370\u20134374. https:\/\/doi.org\/10.1073\/pnas.74.10.4370","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/nar\/7.1.179","volume":"7","author":"H Donis-Keller","year":"1979","unstructured":"Donis-Keller H (1979) Site specific enzymatic cleavage of RNA. Nucleic Acids Res 7:179\u2013192. https:\/\/doi.org\/10.1093\/nar\/7.1.179","journal-title":"Nucleic Acids Res"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"6433","DOI":"10.1093\/nar\/14.16.6433","volume":"14","author":"J Minshull","year":"1986","unstructured":"Minshull J, Hunt T (1986) The use of single-stranded DNA and RNase H to promote quantitative \u201chybrid arrest of translation\u201d of mRNA\/DNA hybrids in reticulocyte lysate cell-free translations. Nucleic Acids Res 14:6433\u20136451. https:\/\/doi.org\/10.1093\/nar\/14.16.6433","journal-title":"Nucleic Acids Res"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1073\/pnas.85.14.5011","volume":"85","author":"RY Walder","year":"1988","unstructured":"Walder RY, Walder JA (1988) Role of RNase H in hybrid-arrested translation by antisense oligonucleotides. Proc Natl Acad Sci U S A 85:5011\u20135015. https:\/\/doi.org\/10.1073\/pnas.85.14.5011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1021\/bi00343a015","volume":"24","author":"KR Blake","year":"1985","unstructured":"Blake KR, Murakami A, Miller PS (1985) Inhibition of rabbit globin mRNA translation by sequence-specific oligodeoxyribonucleotides. Biochemistry 24:6132\u20136138","journal-title":"Biochemistry"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0300-9084(86)80180-8","volume":"68","author":"C Cazenave","year":"1986","unstructured":"Cazenave C, Loreau N, Toulm\u00e9 JJ, H\u00e9l\u00e8ne C (1986) Anti-messenger oligodeoxynucleotides: specific inhibition of rabbit beta-globin synthesis in wheat germ extracts and Xenopus oocytes. Biochimie 68:1063\u20131069","journal-title":"Biochimie"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1093\/nar\/15.12.4717","volume":"15","author":"C Cazenave","year":"1987","unstructured":"Cazenave C, Loreau N, Thuong NT et al (1987) Enzymatic amplification of translation inhibition of rabbit \u03b2-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents. Nucleic Acids Res 15:4717\u20134736. https:\/\/doi.org\/10.1093\/nar\/15.12.4717","journal-title":"Nucleic Acids Res"},{"key":"1_CR34","doi-asserted-by":"crossref","first-page":"13979","DOI":"10.1016\/S0021-9258(18)66969-8","volume":"261","author":"TG Lawson","year":"1986","unstructured":"Lawson TG, Ray BK, Dodds JT et al (1986) Influence of 5\u2032 proximal secondary structure on the translational efficiency of eukaryotic mRNAs and on their interaction with initiation factors. J Biol Chem 261:13979\u201313989","journal-title":"J Biol Chem"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1093\/nar\/13.13.4991","volume":"13","author":"ES Kawasaki","year":"1985","unstructured":"Kawasaki ES (1985) Quantitative hybridization-arrest of mRNA in Xenopus oocytes using single-stranded complementary DNA or oligonucleotide probes. Nucleic Acids Res 13:4991\u20135004. https:\/\/doi.org\/10.1093\/nar\/13.13.4991","journal-title":"Nucleic Acids Res"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.1073\/pnas.84.22.7896","volume":"84","author":"P Dash","year":"1987","unstructured":"Dash P, Lotan I, Knapp M et al (1987) Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity. Proc Natl Acad Sci U S A 84:7896\u20137900. https:\/\/doi.org\/10.1073\/pnas.84.22.7896","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1073\/pnas.83.12.4143","volume":"83","author":"PC Zamecnik","year":"1986","unstructured":"Zamecnik PC, Goodchild J, Taguchi Y, Sarin PS (1986) Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc Natl Acad Sci 83:4143\u20134146. https:\/\/doi.org\/10.1073\/pnas.83.12.4143","journal-title":"Proc Natl Acad Sci"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1073\/pnas.83.9.2787","volume":"83","author":"CC Smith","year":"1986","unstructured":"Smith CC, Aurelian L, Reddy MP et al (1986) Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5. Proc Natl Acad Sci 83:2787\u20132791. https:\/\/doi.org\/10.1073\/pnas.83.9.2787","journal-title":"Proc Natl Acad Sci"},{"key":"1_CR39","doi-asserted-by":"crossref","first-page":"7492","DOI":"10.1016\/S0021-9258(18)47593-X","volume":"262","author":"KC Gupta","year":"1987","unstructured":"Gupta KC (1987) Antisense oligodeoxynucleotides provide insight into mechanism of translation initiation of two Sendai virus mRNAs. J Biol Chem 262:7492\u20137496","journal-title":"J Biol Chem"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"5605","DOI":"10.1093\/nar\/14.14.5605","volume":"14","author":"AWCA Cornelissen","year":"1986","unstructured":"Cornelissen AWCA, Verspieren MP, Toulm\u00e9 J-J et al (1986) The common 5\u2032 terminal sequence on trypanosome mRNAs: a target for anti-messenger oligodeoxynucleotides. Nucleic Acids Res 14:5605\u20135614. https:\/\/doi.org\/10.1093\/nar\/14.14.5605","journal-title":"Nucleic Acids Res"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.3523758","volume":"233","author":"J Walder","year":"1986","unstructured":"Walder J, Eder P, Engman D et al (1986) The 35-nucleotide spliced leader sequence is common to all trypanosome messenger RNA\u2019s. Science 233:569\u2013571. https:\/\/doi.org\/10.1126\/science.3523758","journal-title":"Science"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0378-1119(87)90194-6","volume":"61","author":"P Verspieren","year":"1987","unstructured":"Verspieren P, Cornelissen AW, Thuong NT et al (1987) An acridine-linked oligodeoxynucleotide targeted to the common 5\u2032 end of trypanosome mRNAs kills cultured parasites. Gene 61:307\u2013315","journal-title":"Gene"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0092-8674(87)90238-8","volume":"48","author":"MR Rebagliati","year":"1987","unstructured":"Rebagliati MR, Melton DA (1987) Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell 48:599\u2013605","journal-title":"Cell"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0165-022X(86)90021-7","volume":"13","author":"E Wickstrom","year":"1986","unstructured":"Wickstrom E (1986) Oligodeoxynucleotide stability in subcellular extracts and culture media. J Biochem Biophys Methods 13:97\u2013102. https:\/\/doi.org\/10.1016\/0165-022X(86)90021-7","journal-title":"J Biochem Biophys Methods"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3390\/molecules23061302","volume":"23","author":"V Oberemok","year":"2018","unstructured":"Oberemok V, Laikova K, Repetskaya A et al (2018) A half-century history of applications of antisense oligonucleotides in medicine, agriculture and forestry: we should continue the journey. Molecules 23:1302. https:\/\/doi.org\/10.3390\/molecules23061302","journal-title":"Molecules"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nbt.3765","volume":"35","author":"A Khvorova","year":"2017","unstructured":"Khvorova A, Watts JK (2017) The chemical evolution of oligonucleotide therapies of clinical utility. Nat Biotechnol 35:238\u2013248. https:\/\/doi.org\/10.1038\/nbt.3765","journal-title":"Nat Biotechnol"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/hum.2015.070","volume":"26","author":"KE Lundin","year":"2015","unstructured":"Lundin KE, Gissberg O, Smith CIE (2015) Oligonucleotide therapies: the past and the present. Hum Gene Ther 26:475\u2013485. https:\/\/doi.org\/10.1089\/hum.2015.070","journal-title":"Hum Gene Ther"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1021\/bi00590a017","volume":"18","author":"PS Miller","year":"1979","unstructured":"Miller PS, Yano J, Yano E et al (1979) Nonionic nucleic acid analogues. Synthesis and characterization of dideoxyribonucleoside methylphosphonates. Biochemistry 18:5134\u20135143","journal-title":"Biochemistry"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1021\/ja00970a054","volume":"88","author":"F Eckstein","year":"1966","unstructured":"Eckstein F (1966) Nucleoside Phosphorothioates. J Am Chem Soc 88:4292\u20134294. https:\/\/doi.org\/10.1021\/ja00970a054","journal-title":"J Am Chem Soc"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1021\/ja01033a054","volume":"91","author":"AM Bobst","year":"1969","unstructured":"Bobst AM, Cerutti PA, Rottman F (1969) Structure of poly(2\u2019-O-methyladenylic acid) at acidic and neutral pH. J Am Chem Soc 91:1246\u20131248. https:\/\/doi.org\/10.1021\/ja01033a054","journal-title":"J Am Chem Soc"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"6139","DOI":"10.1021\/bi00343a016","volume":"24","author":"KR Blake","year":"1985","unstructured":"Blake KR, Murakami A, Spitz SA et al (1985) Hybridization arrest of globin synthesis in rabbit reticulocyte lysates and cells by oligodeoxyribonucleoside methylphosphonates. Biochemistry 24:6139\u20136145","journal-title":"Biochemistry"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1093\/nar\/16.8.3341","volume":"16","author":"LJ Maher","year":"1988","unstructured":"Maher LJ, Dolnick BJ (1988) Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylpbosphonates in a cell-free system. Nucleic Acids Res 16:3341\u20133358. https:\/\/doi.org\/10.1093\/nar\/16.8.3341","journal-title":"Nucleic Acids Res"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/0024-3205(91)90480-Y","volume":"49","author":"S Akhtar","year":"1991","unstructured":"Akhtar S, Kole R, Juliano RL (1991) Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci 49:1793\u20131801","journal-title":"Life Sci"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0014-5793(87)80171-0","volume":"215","author":"H Inoue","year":"1987","unstructured":"Inoue H, Hayase Y, Iwai S, Ohtsuka E (1987) Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H. FEBS Lett 215:327\u2013330","journal-title":"FEBS Lett"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0165-022X(90)90084-P","volume":"20","author":"JM Campbell","year":"1990","unstructured":"Campbell JM, Bacon TA, Wickstrom E (1990) Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid. J Biochem Biophys Methods 20:259\u2013267. https:\/\/doi.org\/10.1016\/0165-022X(90)90084-P","journal-title":"J Biochem Biophys Methods"},{"key":"1_CR56","first-page":"6565","volume":"50","author":"JC Reed","year":"1990","unstructured":"Reed JC, Stein C, Subasinghe C et al (1990) Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res 50:6565\u20136570","journal-title":"Cancer Res"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1093\/nar\/18.12.3537","volume":"18","author":"C Baker","year":"1990","unstructured":"Baker C, Holland D, Edge M, Colman A (1990) Effects of oligo sequence and chemistry on the efficiency of oligodeoxyribonucleotide-mediated mRNA cleavage. Nucleic Acids Res 18:3537\u20133543. https:\/\/doi.org\/10.1093\/nar\/18.12.3537","journal-title":"Nucleic Acids Res"},{"key":"1_CR58","unstructured":"Walder J, Walder R (1995) Nucleic acid hybridization and amplification method for detection of specific sequences in which a complementary labeled nucleic acid probe is cleaved. US Patent US5403711A, 4 April 1995"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"7253","DOI":"10.1093\/nar\/17.18.7253","volume":"17","author":"RS Quartin","year":"1989","unstructured":"Quartin RS, Brakel CL, Wetmur G (1989) Number and distribution of methyiphosphonate linkages in oligodeoxynucleotides affect exo- and endonuclease sensitivity and ability to form RNase H substrates. Nucleic Acids Res 17:7253\u20137262. https:\/\/doi.org\/10.1093\/nar\/17.18.7253","journal-title":"Nucleic Acids Res"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"9193","DOI":"10.1093\/nar\/17.22.9193","volume":"17","author":"PJ Furdon","year":"1989","unstructured":"Furdon PJ, Dominski Z, Kole R (1989) RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds. Nucleic Acids Res 17:9193\u20139204. https:\/\/doi.org\/10.1093\/nar\/17.22.9193","journal-title":"Nucleic Acids Res"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"8793","DOI":"10.1021\/bi00489a041","volume":"29","author":"Y Hayase","year":"1990","unstructured":"Hayase Y, Inoue H, Ohtsuka E (1990) Secondary structure in formylmethionine tRNA influences the site-directed cleavage of ribonuclease H using chimeric 2\u2032-O-methyl oligodeoxyribonucleotides. Biochemistry 29:8793\u20138797","journal-title":"Biochemistry"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1073\/pnas.87.4.1401","volume":"87","author":"S Agrawal","year":"1990","unstructured":"Agrawal S, Mayrand SH, Zamecnik PC, Pederson T (1990) Site-specific excision from RNA by RNase H and mixed-phosphate-backbone oligodeoxynucleotides. Proc Natl Acad Sci U S A 87:1401\u20131405. https:\/\/doi.org\/10.1073\/pnas.87.4.1401","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1093\/nar\/18.16.4751","volume":"18","author":"JM Dagle","year":"1990","unstructured":"Dagle JM, Walder JA, Weeks DL (1990) Targeted degradation of mRNA in Xenopus oocytes and embryos directed by modified oligonucleotides: studies of An2 and cyclin in embryogenesis. Nucleic Acids Res 18:4751\u20134757. https:\/\/doi.org\/10.1093\/nar\/18.16.4751","journal-title":"Nucleic Acids Res"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1073\/pnas.88.4.1516","volume":"88","author":"JD Potts","year":"1991","unstructured":"Potts JD, Dagle JM, Walder JA et al (1991) Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3. Proc Natl Acad Sci 88:1516\u20131520. https:\/\/doi.org\/10.1073\/pnas.88.4.1516","journal-title":"Proc Natl Acad Sci"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/328445a0","volume":"328","author":"R Heikkila","year":"1987","unstructured":"Heikkila R, Schwab G, Wickstrom E et al (1987) A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature 328:445\u2013449. https:\/\/doi.org\/10.1038\/328445a0","journal-title":"Nature"},{"key":"1_CR66","first-page":"282","volume":"141","author":"SL Loke","year":"1988","unstructured":"Loke SL, Stein C, Zhang X et al (1988) Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr Top Microbiol Immunol 141:282\u2013289","journal-title":"Curr Top Microbiol Immunol"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/bjc.1989.283","volume":"60","author":"DM Tidd","year":"1989","unstructured":"Tidd DM, Warenius HM (1989) Partial protection of oncogene, anti-sense oligodeoxynucleotides against serum nuclease degradation using terminal methylphosphonate groups. Br J Cancer 60:343\u2013350. https:\/\/doi.org\/10.1038\/bjc.1989.283","journal-title":"Br J Cancer"},{"key":"1_CR68","first-page":"117","volume":"3","author":"DM Tidd","year":"1988","unstructured":"Tidd DM, Hawley P, Warenius HM, Gibson I (1988) Evaluation of N-ras oncogene anti-sense, sense and nonsense sequence methylphosphonate oligonucleotide analogues. Anticancer Drug Des 3:117\u2013127","journal-title":"Anticancer Drug Des"},{"key":"1_CR69","first-page":"37","volume":"7","author":"RV Giles","year":"1992","unstructured":"Giles RV, Tidd DM (1992) Enhanced RNase H activity with methylphosphonodiester\/phosphodiester chimeric antisense oligodeoxynucleotides. Anticancer Drug Des 7:37\u201348","journal-title":"Anticancer Drug Des"},{"key":"1_CR70","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.1016\/S0021-9258(19)85268-7","volume":"268","author":"BP Monia","year":"1993","unstructured":"Monia BP, Lesnik EA, Gonzalez C et al (1993) Evaluation of 2\u2032-modified oligonucleotides containing 2\u2032-deoxy gaps as antisense inhibitors of gene expression. J Biol Chem 268:14514\u201314522","journal-title":"J Biol Chem"},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/nar\/20.4.763","volume":"20","author":"RV Giles","year":"1992","unstructured":"Giles RV, Tidd DM (1992) Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester\/phosphodiester structures. Nucleic Acids Res 20:763\u2013770. https:\/\/doi.org\/10.1093\/nar\/20.4.763","journal-title":"Nucleic Acids Res"},{"key":"1_CR72","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1042\/bj3120599","volume":"312","author":"ST Crooke","year":"1995","unstructured":"Crooke ST, Lemonidis KM, Neilson L et al (1995) Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes. Biochem J 312:599\u2013608. https:\/\/doi.org\/10.1042\/bj3120599","journal-title":"Biochem J"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1074-5521(00)00058-2","volume":"8","author":"DA Braasch","year":"2001","unstructured":"Braasch DA, Corey DR (2001) Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem Biol 8:1\u20137","journal-title":"Chem Biol"},{"key":"1_CR74","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1016\/S0040-4039(98)01084-3","volume":"39","author":"S Obika","year":"1998","unstructured":"Obika S, Nanbu D, Hari Y et al (1998) Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2\u2032-O,4\u2032-C-methyleneribonucleosides. Tetrahedron Lett 39:5401\u20135404. https:\/\/doi.org\/10.1016\/S0040-4039(98)01084-3","journal-title":"Tetrahedron Lett"},{"key":"1_CR75","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1016\/S0040-4020(98)00094-5","volume":"54","author":"AA Koshkin","year":"1998","unstructured":"Koshkin AA, Singh SK, Nielsen P et al (1998) LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron 54:3607\u20133630. https:\/\/doi.org\/10.1016\/S0040-4020(98)00094-5","journal-title":"Tetrahedron"},{"key":"1_CR76","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1073\/pnas.97.10.5633","volume":"97","author":"C Wahlestedt","year":"2000","unstructured":"Wahlestedt C, Salmi P, Good L et al (2000) Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci U S A 97:5633\u20135638. https:\/\/doi.org\/10.1073\/pnas.97.10.5633","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR77","doi-asserted-by":"publisher","first-page":"30377","DOI":"10.1038\/srep30377","volume":"6","author":"T Kasuya","year":"2016","unstructured":"Kasuya T, Hori S, Watanabe A et al (2016) Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides. Sci Rep 6:30377. https:\/\/doi.org\/10.1038\/srep30377","journal-title":"Sci Rep"},{"key":"1_CR78","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/nar\/gkl1071","volume":"35","author":"EE Swayze","year":"2007","unstructured":"Swayze EE, Siwkowski AM, Wancewicz EV et al (2007) Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic Acids Res 35:687\u2013700. https:\/\/doi.org\/10.1093\/nar\/gkl1071","journal-title":"Nucleic Acids Res"},{"key":"1_CR79","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/toxsci\/kft278","volume":"138","author":"S Kakiuchi-Kiyota","year":"2014","unstructured":"Kakiuchi-Kiyota S, Koza-Taylor PH, Mantena SR et al (2014) Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice. Toxicol Sci 138:234\u2013248. https:\/\/doi.org\/10.1093\/toxsci\/kft278","journal-title":"Toxicol Sci"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1093\/nar\/gkv1210","volume":"44","author":"SA Burel","year":"2016","unstructured":"Burel SA, Hart CE, Cauntay P et al (2016) Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts. Nucleic Acids Res 44:2093\u20132109. https:\/\/doi.org\/10.1093\/nar\/gkv1210","journal-title":"Nucleic Acids Res"},{"key":"1_CR81","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/hlca.19950780219","volume":"78","author":"P Martin","year":"1995","unstructured":"Martin P (1995) Ein neuer Zugang zu 2\u2019-O-Alkylribonucleosiden und Eigenschaften deren Oligonucleotide. Helv Chim Acta 78:486\u2013504. https:\/\/doi.org\/10.1002\/hlca.19950780219","journal-title":"Helv Chim Acta"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0006-2952(99)00412-8","volume":"59","author":"M Garay","year":"2000","unstructured":"Garay M, Gaarde W, Monia BP et al (2000) Inhibition of hypoxia\/reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells. Biochem Pharmacol 59:1033\u20131043. https:\/\/doi.org\/10.1016\/S0006-2952(99)00412-8","journal-title":"Biochem Pharmacol"},{"key":"1_CR83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1124\/mol.51.2.209","volume":"51","author":"L Levesque","year":"1997","unstructured":"Levesque L, Dean NM, Sasmor H, Crooke ST (1997) Antisense oligonucleotides targeting human protein kinase C-alpha inhibit phorbol ester-induced reduction of bradykinin-evoked calcium mobilization in A549 cells. Mol Pharmacol 51:209\u2013216","journal-title":"Mol Pharmacol"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fchem.2014.00087","volume":"2","author":"PMD Moreno","year":"2014","unstructured":"Moreno PMD, P\u00eago AP (2014) Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic. Front Chem 2:87. https:\/\/doi.org\/10.3389\/fchem.2014.00087","journal-title":"Front Chem"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.omtn.2017.05.007","volume":"7","author":"D Jauvin","year":"2017","unstructured":"Jauvin D, Chr\u00e9tien J, Pandey SK et al (2017) Targeting DMPK with antisense oligonucleotide improves muscle strength in Myotonic dystrophy type 1 mice. Mol Ther Nucleic Acids 7:465\u2013474. https:\/\/doi.org\/10.1016\/j.omtn.2017.05.007","journal-title":"Mol Ther Nucleic Acids"},{"key":"1_CR86","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.5551\/jat.RV16001","volume":"23","author":"T Yamamoto","year":"2016","unstructured":"Yamamoto T, Wada F, Harada-Shiba M (2016) Development of antisense drugs for dyslipidemia. J Atheroscler Thromb 23:1011\u20131025. https:\/\/doi.org\/10.5551\/jat.RV16001","journal-title":"J Atheroscler Thromb"},{"key":"1_CR87","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/CIRCRESAHA.117.311311","volume":"123","author":"T Lucas","year":"2018","unstructured":"Lucas T, Bonauer A, Dimmeler S (2018) RNA therapeutics in cardiovascular disease. Circ Res 123:205\u2013220. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311311","journal-title":"Circ Res"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","volume":"32","author":"N Amodio","year":"2018","unstructured":"Amodio N, Stamato MA, Juli G et al (2018) Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. Leukemia 32:1948\u20131957. https:\/\/doi.org\/10.1038\/s41375-018-0067-3","journal-title":"Leukemia"},{"issue":"6","key":"1_CR89","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1089\/cbr.2018.2510","volume":"34","author":"M Salehi","year":"2019","unstructured":"Salehi M, Sharifi M, Bagheri M (2019) Knockdown of long noncoding RNA Plasmacytoma variant translocation 1 with antisense locked nucleic acid GapmeRs exerts tumor-suppressive functions in human acute Erythroleukemia cells through Downregulation of C-MYC expression. Cancer Biother Radiopharm 34(6):371\u2013379. https:\/\/doi.org\/10.1089\/cbr.2018.2510","journal-title":"Cancer Biother Radiopharm"},{"issue":"24","key":"1_CR90","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1161\/CIRCULATIONAHA.118.036769","volume":"139","author":"P Mirtschink","year":"2019","unstructured":"Mirtschink P, Bischof C, Pham M-D et al (2019) Inhibition of the HIF1\u03b1-induced Cardiospecific HERNA1 eRNA protects from heart disease. Circulation 139(24):2778\u20132792. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036769","journal-title":"Circulation"},{"key":"1_CR91","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1124\/dmd.106.012401","volume":"35","author":"RZ Yu","year":"2006","unstructured":"Yu RZ, Kim T-W, Hong A et al (2006) Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human Apolipoprotein B-100. Drug Metab Dispos 35:460\u2013468. https:\/\/doi.org\/10.1124\/dmd.106.012401","journal-title":"Drug Metab Dispos"},{"key":"1_CR92","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/nass\/nrn280","volume":"52","author":"PP Seth","year":"2008","unstructured":"Seth PP, Siwkowski A, Allerson CR et al (2008) Design, synthesis and evaluation of constrained methoxyethyl (cMOE) and constrained ethyl (cEt) nucleoside analogs. Nucleic Acids Symp Ser (Oxf) 52:553\u2013554. https:\/\/doi.org\/10.1093\/nass\/nrn280","journal-title":"Nucleic Acids Symp Ser (Oxf)"},{"issue":"6","key":"1_CR93","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41587-019-0106-2","volume":"37","author":"W Shen","year":"2019","unstructured":"Shen W, De Hoyos CL, Migawa MT et al (2019) Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index. Nat Biotechnol 37(6):640\u2013650. https:\/\/doi.org\/10.1038\/s41587-019-0106-2","journal-title":"Nat Biotechnol"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1089\/nat.2013.0436","volume":"23","author":"PH Hagedorn","year":"2013","unstructured":"Hagedorn PH, Yakimov V, Ottosen S et al (2013) Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification pattern. Nucleic Acid Ther 23:302\u2013310. https:\/\/doi.org\/10.1089\/nat.2013.0436","journal-title":"Nucleic Acid Ther"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1093\/nar\/gku142","volume":"42","author":"AD Burdick","year":"2014","unstructured":"Burdick AD, Sciabola S, Mantena SR et al (2014) Sequence motifs associated with hepatotoxicity of locked nucleic acid\u2014modified antisense oligonucleotides. Nucleic Acids Res 42:4882\u20134891. https:\/\/doi.org\/10.1093\/nar\/gku142","journal-title":"Nucleic Acids Res"},{"key":"1_CR96","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1089\/nat.2018.0724","volume":"28","author":"T Kasuya","year":"2018","unstructured":"Kasuya T, Kugimiya A (2018) Role of computationally evaluated target specificity in the hepatotoxicity of Gapmer antisense oligonucleotides. Nucleic Acid Ther 28:312\u2013317. https:\/\/doi.org\/10.1089\/nat.2018.0724","journal-title":"Nucleic Acid Ther"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1080\/07391102.2018.1498390","volume":"37","author":"MVN Uppuladinne","year":"2019","unstructured":"Uppuladinne MVN, Sonavane UB, Deka RC, Joshi RR (2019) Structural insight into antisense gapmer-RNA oligomer duplexes through molecular dynamics simulations. J Biomol Struct Dyn 37:2823\u20132836. https:\/\/doi.org\/10.1080\/07391102.2018.1498390","journal-title":"J Biomol Struct Dyn"},{"key":"1_CR98","doi-asserted-by":"publisher","first-page":"37721","DOI":"10.1038\/srep37721","volume":"6","author":"MHUT Fazil","year":"2016","unstructured":"Fazil MHUT, Ong ST, Chalasani MLS et al (2016) GapmeR cellular internalization by macropinocytosis induces sequence-specific gene silencing in human primary T-cells. Sci Rep 6:37721. https:\/\/doi.org\/10.1038\/srep37721","journal-title":"Sci Rep"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.ymthe.2017.05.009","volume":"25","author":"ML Hvam","year":"2017","unstructured":"Hvam ML, Cai Y, Dagn\u00e6s-Hansen F et al (2017) Fatty acid-modified Gapmer antisense oligonucleotide and serum albumin constructs for pharmacokinetic modulation. Mol Ther 25:1710\u20131717. https:\/\/doi.org\/10.1016\/j.ymthe.2017.05.009","journal-title":"Mol Ther"},{"key":"1_CR100","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nbt.3779","volume":"35","author":"ST Crooke","year":"2017","unstructured":"Crooke ST, Wang S, Vickers TA et al (2017) Cellular uptake and trafficking of antisense oligonucleotides. Nat Biotechnol 35:230\u2013237. https:\/\/doi.org\/10.1038\/nbt.3779","journal-title":"Nat Biotechnol"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.ymthe.2017.06.002","volume":"25","author":"X-H Liang","year":"2017","unstructured":"Liang X-H, Sun H, Nichols JG, Crooke ST (2017) RNase H1-dependent antisense oligonucleotides are robustly active in directing RNA cleavage in both the cytoplasm and the nucleus. Mol Ther 25:2075\u20132092. https:\/\/doi.org\/10.1016\/j.ymthe.2017.06.002","journal-title":"Mol Ther"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s11095-016-2063-5","volume":"34","author":"X Cheng","year":"2017","unstructured":"Cheng X, Liu Q, Li H et al (2017) Lipid nanoparticles loaded with an antisense oligonucleotide Gapmer against Bcl-2 for treatment of lung cancer. Pharm Res 34:310\u2013320","journal-title":"Pharm Res"}],"container-title":["Methods in Molecular Biology","Gapmers"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0771-8_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T01:52:09Z","timestamp":1617069129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0771-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071607701","9781071607718"],"references-count":102,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0771-8_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"1 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}